Were you looking for information about Rituxan? Rituxin is a common misspelling of Rituxan.
Rituxan® (rituximab) is a drug licensed to treat rheumatoid arthritis, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. It has also been approved to treat Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA). This product is administered intravenously by your healthcare provider. It works by binding to specific cells in the body and destroying them. As with any drug, side effects are possible with Rituxan, including fever, chills, and infections.
(For more information, click Rituxan. This article offers an overview of the drug's effects, dosing guidelines, and possible safety concerns. You can also click any of the links in the box to the right for specific information.)